Endoscopy 2004; 36(6): 522-526
DOI: 10.1055/s-2004-814400
Original Article
© Georg Thieme Verlag Stuttgart · New York

Risk Factors for Mortality in Patients Undergoing Percutaneous Endoscopic Gastrostomy

A.  Lang1 , E.  Bardan1 , Y.  Chowers1 , E.  Sakhnini1 , H.  H.  Fidder1 , S.  Bar-Meir1 , B.  Avidan1
  • 1The Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, University of Tel-Aviv, Ramat-Gan, Israel
Further Information

Publication History

Submitted 26 October 2003

Accepted after Revision 21 January 2004

Publication Date:
17 June 2004 (online)

Background and Study Aims: Percutaneous endoscopic gastrostomy (PEG) is a method used for feeding patients who are unable to eat. High early mortality rates among hospitalized patients have been reported. The aim of this study was to shed light on the risk factors for early mortality after PEG tube insertion. Patients and Methods: Outpatients from nursing homes and hospitalized patients who underwent PEG between July 1995 and July 2001 were compared. Survival analysis was used to assess mortality after PEG. In a logistic regression analysis, mortality within 30 days among hospitalized patients was chosen as the outcome variable and the predictor variables were demographic characteristics, co-morbid conditions, and indication for PEG. Results: A total of 502 PEG tubes were inserted in 419 hospitalized and 83 nursing-home patients. The prevalence of co-morbid conditions was similar in the two groups. Both the 30- and 60-day mortality rates were around six times higher in the hospitalized patient group than in the nursing-home patient group (30-day mortality rate 8 % vs. 1.2 %, P = 0.034; 60-day mortality rate 12 % vs. 2.4 %, P = 0.016). Risk factors for 30-day mortality among hospitalized patients were: serum albumin < 3 g/dl (odds ratio 2.82, 95 % CI 1.34 - 5.96), chronic obstructive pulmonary disease (odds ratio 2.79, 95 % CI 1.26 - 6.14), and diabetes mellitus (odds ratio 2.44, 95 % CI 1.20 - 4.97). Conclusions: Compared with nursing-home patients, hospitalized patients are at higher risk for early mortality after PEG. The presence of diabetes, chronic obstructive pulmonary disease, and a low serum albumin level each increase the 30-day mortality risk among hospitalized patients threefold.

References

  • 1 Gauderer M W, Ponsky J L, Izant R J Jr.. Gastrostomy without laparotomy: a percutaneous endoscopic technique.  J Pediatr Surg. 1980;  15 872-875
  • 2 Ponsky J L, Gauderer M W. Percutaneous endoscopic gastrostomy: a nonoperative technique for feeding gastrostomy.  Gastrointest Endosc. 1981;  27 9-11
  • 3 Himal H S, Schumacher S. Endoscopic vs. surgical gastrostomy for enteral nutrition.  Surg Endosc. 1987;  1 33-35
  • 4 Grant J P. Comparison of percutaneous endoscopic gastrostomy with Stamm gastrostomy.  Ann Surg. 1988;  207 598-603
  • 5 Larson D E, Burton D D, Schroeder K W, DiMagno E P. Percutaneous endoscopic gastrostomy: indications, success, complications, and mortality in 314 consecutive patients.  Gastroenterology. 1987;  93 48-52
  • 6 Kaw M, Sekas G. Long-term follow-up of consequences of percutaneous endoscopic gastrostomy (PEG) tubes in nursing home patients.  Dig Dis Sci. 1994;  39 738-743
  • 7 Light V L, Slezak F A, Porter J A. et al . Predictive factors for early mortality after percutaneous endoscopic gastrostomy.  Gastrointest Endosc. 1995;  42 330-335
  • 8 Clarkston W K, Smith O J, Walden J M. Percutaneous endoscopic gastrostomy and early mortality.  South Med J. 1990;  83 1433-1436
  • 9 Wolfsen H C, Kozarek R A, Ball T J. et al . Long-term survival in patients undergoing percutaneous endoscopic gastrostomy and jejunostomy.  Am J Gastroenterol. 1990;  85 1120-1122
  • 10 Taylor C A, Larson D E, Ballard D J. et al . Predictors of outcome after percutaneous endoscopic gastrostomy: a community-based study.  Mayo Clin Proc. 1992;  67 1042-1049
  • 11 Kobayashi K, Cooper G S, Grant M D, Rudberg M A. Gastrostomy placement and mortality among hospitalized Medicare beneficiaries.  Gastrointest Endosc. 1999;  49 810-811
  • 12 Abuksis G, Mor M, Segal N. et al . Percutaneous endoscopic gastrostomy: high mortality rates in hospitalized patients.  Am J Gastroenterol. 2000;  95 128-132
  • 13 Rothschild M A, Oratz M, Schreiber S S. Albumin synthesis: 1.  N Engl J Med. 1972;  286 748-757
  • 14 Rothschild M A, Oratz M, Schreiber S S. Serum albumin.  Hepatology. 1988;  8 385-401
  • 15 Fleck A, Raines G, Hawker F. et al . Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury.  Lancet. 1985;  1 781-784
  • 16 Hoogwerf B J. Postoperative management of the diabetic patient.  Med Clin N Am. 2001;  85 1213-1228
  • 17 Loser C, Wolters S, Folsch U R. Enteral long-term nutrition via percutaneous endoscopic gastrostomy (PEG) in 210 patients: a 4-year prospective study.  Dig Dis Sci. 1998;  43 2549-2557
  • 18 Ho C S, Yee A C, McPherson R. Complications of surgical and percutaneous nonendoscopic gastrostomy: review of 233 patients.  Gastroenterology. 1988;  95 1206-1210
  • 19 Patel P H, Thomas E. Risk factors for pneumonia after percutaneous endoscopic gastrostomy.  J Clin Gastroenterol. 1990;  12 389-392
  • 20 Kadakia S C, Sullivan H O, Starnes E. Percutaneous endoscopic gastrostomy or jejunostomy and the incidence of aspiration in 79 patients.  Am J Surg. 1992;  164 114-118
  • 21 Wilson R. The role of infection in COPD.  Chest. 1998;  113 242S-248S
  • 22 Sanders D S, Carter M J, D'Silva J. et al . Survival analysis in percutaneous endoscopic gastrostomy feeding: a worse outcome in patients with dementia.  Am J Gastroenterol. 2000;  95 1472-1475
  • 23 Angus F, Burakoff R. The percutaneous endoscopic gastrostomy tube. Medical and ethical issues in placement.  Am J Gastroenterol. 2003;  98 272-277
  • 24 Gillick M R. Rethinking the role of tube feeding in patients with advanced dementia.  N Engl J Med. 2000;  342 206-210

A. Lang, M. D.

The Chaim Sheba Medical Center, Affiliated to the Tel-Aviv University

Tel-Hashomer 52621 · Israel

Fax: +972-3-5303160

Email: langa@sheba.health.gov.il

    >